“…We have, therefore, applied extracorporeal circulation for the activation of the mononuclear cells. Up to the present time cancer treatments utilizing extracorporeal circulation have been aimed at the removal of circulating immunosuppressive substances, using a protein A column [l, 6, 20, 31, 32] and plasma exchanges [2,3,8,10,13,25,29]. We have been developing an immunomodulator, that can enhance the immune system in a living body [15,24,[26][27][28].…”